Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Universal Display
OLED
$3.89B
| $27.5M | 0.02% |
160,873
+137,687
| +594% | +$28.5M |
|
1027
PUT
Mondelez International
MDLZ
$82.6B
| $27.5M | 0.02% |
472,600
+307,600
| +186% | +$19.1M |
|
1028
Gen Digital
GEN
$17.4B
| $27.5M | 0.02% |
1,086,743
-2,192,990
| -67% | -$57.1M |
|
|
ORGN
1029
DELISTED
Origin Materials
ORGN
| $27.5M | 0.02% |
134,513
+66,238
| +97% | +$13.6M |
|
|
ITCI
1030
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $27.5M | 0.02% |
737,151
+94,173
| +15% | +$3.27M |
|
1031
C3.ai
AI
$1.57B
| $27.3M | 0.02% |
589,393
+449,475
| +321% | +$22.9M |
|
1032
Marathon Petroleum
MPC
$102B
| $27.2M | 0.02% |
440,224
-3,006,514
| -87% | -$173M |
|
1033
Home Depot
HD
$336B
| $27.2M | 0.02% |
82,788
-85,497
| -51% | -$28.1M |
|
1034
PUT
3M
MMM
$92.3B
| $27.1M | 0.02% |
184,902
-142,084
| -43% | -$23M |
|
1035
Arrow Electronics
ARW
$10.3B
| $27.1M | 0.02% |
241,111
+212,142
| +732% | +$24.5M |
|
1036
Watsco Inc
WSO
$12.8B
| $27.1M | 0.02% |
102,258
+90,960
| +805% | +$25.5M |
|
1037
CALL
State Street SPDR S&P Biotech ETF
XBI
$11.5B
| $27M | 0.02% |
215,000
-103,100
| -32% | -$13.3M |
|
|
1038
CALL
Linde
LIN
$226B
| $27M | 0.02% |
92,100
+90,800
| +6,985% | +$27.6M |
|
|
RBAC
1039
DELISTED
RedBall Acquisition Corp.
RBAC
| $27M | 0.02% |
2,740,079
+603,289
| +28% | +$5.91M |
|
1040
Jones Lang LaSalle
JLL
$17.8B
| $27M | 0.02% |
108,664
+72,135
| +197% | +$16.5M |
|
1041
La-Z-Boy
LZB
$1.29B
| $26.9M | 0.02% |
835,950
+159,514
| +24% | +$5.5M |
|
1042
Texas Instruments
TXN
$236B
| $26.9M | 0.02% |
140,089
-267,524
| -66% | -$51M |
|
1043
CALL
Uber
UBER
$162B
| $26.9M | 0.02% |
600,900
+467,000
| +349% | +$20.4M |
|
1044
Crocs
CROX
$6.03B
| $26.9M | 0.02% |
187,465
-34,249
| -15% | -$4.7M |
|
|
FBC
1045
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $26.9M | 0.02% |
529,650
+395,556
| +295% | +$18.7M |
|
1046
PUT
Pinterest
PINS
$13.3B
| $26.9M | 0.02% |
527,500
+407,500
| +340% | +$25M |
|
|
MIME
1047
DELISTED
Mimecast Limited
MIME
| $26.8M | 0.02% |
422,045
+10,213
| +2% | +$625K |
|
1048
CALL
MetLife
MET
$61.1B
| $26.8M | 0.02% |
434,700
+49,600
| +13% | +$2.99M |
|
1049
Castle Biosciences
CSTL
$1.02B
| $26.8M | 0.02% |
+403,359
| New | +$28.4M |
|
1050
Host Hotels & Resorts
HST
$15.9B
| $26.8M | 0.02% |
1,641,149
+973,006
| +146% | +$15.8M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.